Obermann, E C; Eppenberger-Castori, S; Tapia, C (2012). [Assessment of proliferation: core biopsy or resection specimen? Discrepancies in breast cancer with low and high proliferation]. Pathologe, 33(3), pp. 245-50. Heidelberg: Springer-Verlag 10.1007/s00292-012-1583-y
|
Text
292_2012_Article_1583.pdf - Published Version Available under License Publisher holds Copyright. Download (706kB) | Preview |
The assessment of the proliferation fraction is becoming more and more important; however, there is no consensus concerning optimal validation. Depending on the institute the proliferation fraction is determined either from a core biopsy (SB) or resection specimen (OP).
Item Type: |
Journal Article (Further Contribution) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Service Sector > Institute of Pathology |
UniBE Contributor: |
Tapia, Coya |
ISSN: |
0172-8113 |
Publisher: |
Springer-Verlag |
Language: |
German |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:32 |
Last Modified: |
05 Dec 2022 14:10 |
Publisher DOI: |
10.1007/s00292-012-1583-y |
PubMed ID: |
22576598 |
Web of Science ID: |
000304107400009 |
BORIS DOI: |
10.7892/boris.12450 |
URI: |
https://boris.unibe.ch/id/eprint/12450 (FactScience: 218794) |